Skip to content

Commercialization



The lead commercializing partner and managing party for products resulting from this project is DVS Sciences Inc.

For ordering information, please click here.

CyTOF™

CyTOF™

Instrumentation for massively multiplexed analysis of individual cells or beads.

MAXPAR™

MAXPAR™

Reagents for multiplexed bioassays of bulk or discrete samples.

This project is funded by Genome Canada through the Ontario Genomics Institute:

Genome Canada Ontario Genomics Institute - The Future is in Our Genes.

Complementary funding is gratefully acknowledged from:

News & Events

Raising the Bar: The Royal Society of Chemistry has published an interview with Scott Tanner.

 

Click here to find out about upcoming and past events.

 

Publications

 

Click here for more publications.